Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition.
Glatzel et al.pdf
after embargo allowed publisher's ...
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsGlatzel, Daniel K
MetadataShow full item record
AbstractThe enzyme acetyl-CoA carboxylase (ACC) plays a crucial role in fatty acid metabolism. In recent years, ACC has been recognized as a promising drug target for treating different diseases. However, the role of ACC in vascular endothelial cells (ECs) has been neglected so far. To characterize the role of ACC, we used the ACC inhibitor, soraphen A, as a chemical tool, and also a gene silencing approach. We found that ACC1 was the predominant isoform in human umbilical vein ECs as well as in human microvascular ECs and that soraphen A reduced the levels of malonyl-CoA. We revealed that ACC inhibition shifted the lipid composition of EC membranes. Accordingly, membrane fluidity, filopodia formation, and migratory capacity were reduced. The antimigratory action of soraphen A depended on an increase in the cellular proportion of PUFAs and, most importantly, on a decreased level of phosphatidylglycerol. Our study provides a causal link between ACC, membrane lipid composition, and cell migration in ECs. Soraphen A represents a useful chemical tool to investigate the role of fatty acid metabolism in ECs and ACC inhibition offers a new and valuable therapeutic perspective for the treatment of EC migration-related diseases.
CitationAcetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition. 2018, 59 (2):298-311 J. Lipid Res.
AffiliationHIPS, Helmholtz-Institute für pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
JournalJournal of lipid research
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/
- Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells.
- Authors: Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, Brusselmans K, Verhoeven G, Swinnen JV
- Issue date: 2007 Sep 1
- Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.
- Authors: Jump DB, Torres-Gonzalez M, Olson LK
- Issue date: 2011 Mar 1
- Inhibition of acetyl-CoA carboxylases by soraphen A prevents lipid accumulation and adipocyte differentiation in 3T3-L1 cells.
- Authors: Cordonier EL, Jarecke SK, Hollinger FE, Zempleni J
- Issue date: 2016 Jun 5
- Expression and characterization of recombinant fungal acetyl-CoA carboxylase and isolation of a soraphen-binding domain.
- Authors: Weatherly SC, Volrath SL, Elich TD
- Issue date: 2004 May 15
- Synthesis and characterization of a BODIPY-labeled derivative of Soraphen A that binds to acetyl-CoA carboxylase.
- Authors: Raymer B, Kavana M, Price A, Wang B, Corcoran L, Kulathila R, Groarke J, Mann T
- Issue date: 2009 May 15